ADVANCING A HEALTHIER TOMORROW
OUR WORK
Advancing research. Improving lives.
A healthier, more equitable world.
01
THE ISSUES
According to the WHO, at least 30 new diseases have emerged in the last 20 years and now together threaten the health of hundreds of millions of people. For many of these diseases, there is no treatment, cure or vaccine.
We are standing on the brink of a global crisis in infectious diseases. No country is safe from them. No country can any longer afford to ignore their threat. Not only are new diseases emerging, the treatment for existing diseases has become less reliable. Antibiotics and other life-saving drugs used against many diseases are rapidly losing their effectiveness as bacteria and other microbes develop resistance to them.
Tuberculosis has been named by WHO as one of 10 leading causes of death in the world and it is a disease that occurs in every part of the world. According to the WHO latest report in 2019, an estimated 10 million people fell ill with tuberculosis worldwide in 2018. This included 5.7 million men, 3.2 million women and 1.1 million children. An estimated 1.5 million people died of the disease in 2018.
10 million
new TB cases worldwide each year
1.5 million
people die from the disease annually
4 billion
people are at risk from tuberculosis worldwide
02
OUR APPROACH
We at The Mueller Health Foundation are particularly interested in finding innovative solutions to infectious diseases that are difficult to treat, particularly due to the latent nature of the disease as well as due to drug resistance. Our strategy and approach is based on three strategic pillars that are needed to effectively fight infectious diseases:
03 | CLINICAL RESEARCH
Providing grants to organizations focused on conducting translational basic and clinical research into novel treatment options, epidemiology, pathogenesis, transmission, diagnosis and management for drug resistant infectious diseases. This also includes fostering the creation of public-private partnerships and collaborations with those interested in supporting research on drug resistant infectious diseases.
ADVANCING SCIENCE. CHANGING LIVES.
We support innovative research to drive new treatment options and build a healthier, more equitable future.
04 | TUBERCULOSIS INITIATIVE
Since inception of The Mueller Health Foundation, our main focus has been primarily on the management of multidrug resistance (MDR), extensively drug resistant (XDR) and incurable forms of tuberculosis, which pose enormous challenges similar to those in the pre-antibiotics era. Through our initiatives we hope to tackle these challenges by:
- Finding new cures.
- Improving and expediting limited and often toxic treatment options that can last up to 2 years.
- Making treatment options affordable.
- Decreasing high morbidity and mortality rates.
- Supporting alternative methods to prevent disease transmission and patient-oriented care.
The Mueller Health Foundation focuses on four core functions to address TB:
- Funding bold and innovative research to find new treatment solutions.
- Developing new strategies and educational programs for TB prevention, care and control.
- Fostering collection and access to valuable TB data using Blockchain and AI.
- Supporting cross-sectoral partnerships to fight against TB.
FEATURED STORY
Boston Children’s Hospital
New Results in the Drug Resistant Tuberculosis Research
IMPACT
Come and take a look at the impacts The Mueller Health Foundation and its partners are having by clicking on the Read More button below!
Please come back periodically to check for exciting updates on how our projects and programs are changing the world.